Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smyth

Showing results (191-200 of 294) with videos related to

Pageof 30
Sort By:
Peptides|January 1, 1995
Metabolism of the anticancer peptide H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2D A Jones, J Cummings, S P Langdon, et al.
The Journal of Urology|May 1, 1991
The effects of recombinant human interferon-gamma on a panel of human bladder cancer cell linesS Hawkyard, K James, S Prescott, et al.
Optics Express|January 26, 2012
Performance improvement of 10 Gb/s direct modulation OFDM by optical injection using monolithically integrated Discrete Mode lasersC Browning, K Shi, S Latkowski, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapyP G Harper, M B Dally, D M Geddes, et al.
British Journal of Cancer|June 11, 1999
[Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanismA C MacKinnon, R A Armstrong, C M Waters, et al.
British Medical Journal (Clinical Research Ed.)|November 22, 1986
Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatinP S Warrington, S G Allan, M A Cornbleet, et al.
British Journal of Cancer|May 1, 1992
Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cellsJ M Bartlett, G J Rabiasz, W N Scott, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I study of methylacetylenic putrescine, an inhibitor of polyamine biosynthesisM A Cornbleet, A Kingsnorth, G P Tell, et al.
British Journal of Cancer|March 26, 1998
Dose-limiting neurotoxicity in a phase I study of penclomedine (NSC 388720, CRC 88-04), a synthetic alpha-picoline derivative, administered intravenouslyD I Jodrell, A Bowman, M Stewart, et al.
Cancer Research|August 3, 2005
Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancerKenneth Macleod, Peter Mullen, Jane Sewell, et al.
Pageof 30

Showing results (191-200 of 294) with videos related to

Sort By:
Pageof 30
Peptides|January 1, 1995
Metabolism of the anticancer peptide H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2D A Jones, J Cummings, S P Langdon, et al.
The Journal of Urology|May 1, 1991
The effects of recombinant human interferon-gamma on a panel of human bladder cancer cell linesS Hawkyard, K James, S Prescott, et al.
Optics Express|January 26, 2012
Performance improvement of 10 Gb/s direct modulation OFDM by optical injection using monolithically integrated Discrete Mode lasersC Browning, K Shi, S Latkowski, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapyP G Harper, M B Dally, D M Geddes, et al.
British Journal of Cancer|June 11, 1999
[Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanismA C MacKinnon, R A Armstrong, C M Waters, et al.
British Medical Journal (Clinical Research Ed.)|November 22, 1986
Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatinP S Warrington, S G Allan, M A Cornbleet, et al.
British Journal of Cancer|May 1, 1992
Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cellsJ M Bartlett, G J Rabiasz, W N Scott, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I study of methylacetylenic putrescine, an inhibitor of polyamine biosynthesisM A Cornbleet, A Kingsnorth, G P Tell, et al.
British Journal of Cancer|March 26, 1998
Dose-limiting neurotoxicity in a phase I study of penclomedine (NSC 388720, CRC 88-04), a synthetic alpha-picoline derivative, administered intravenouslyD I Jodrell, A Bowman, M Stewart, et al.
Cancer Research|August 3, 2005
Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancerKenneth Macleod, Peter Mullen, Jane Sewell, et al.
Pageof 30